Cited by 2,953Lipoproteins and Cardiovascular HealthInflammatory Biomarkers in Disease PrognosisAdipokines, Inflammation, and Metabolic Diseases

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease

Open access

Danesh, John, Wheeler, Jeremy G., Hirschfield, Gideon M., Eda, Shinichi, Eiriksdottir, Gudny, Rumley, Ann, Lowe, Gordon D.O., Pepys, Mark B., Gudnason, Vilmundur·2004·New England Journal of Medicine

DOI 10.1056/nejmoa032804

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: C-reactive protein is an inflammatory marker believed to be of value in the prediction of coronary events. We report data from a large study of C-reactive protein and other circulating inflammatory markers, as well as updated meta-analyses, to evaluate their relevance to the prediction of coronary heart disease. METHODS: Measurements were made in samples obtained at base line from up to 2459 patients who had a nonfatal myocardial infarction or died of coronary heart disease during the study and from up to 3969 controls without a coronary heart disease event in the Reykjavik prospective study of 18,569 participants. Measurements were made in paired samples obtained an average of 12 years apart from 379 of these participants in order to quantify within-person fluctuations in inflammatory marker levels. RESULTS: The long-term stability of C-reactive protein values (within-person correlation coefficient, 0.59; 95 percent confidence interval, 0.52 to 0.66) was similar to that of both blood pressure and total serum cholesterol. After adjustment for base-line values for established risk factors, the odds ratio for coronary heart disease was 1.45 (95 percent confidence interval, 1.25 to 1.68) in a comparison of participants in the top third of the group with respect to base-line C-reactive protein values with those in the bottom third, and similar overall findings were observed in an updated meta-analysis involving a total of 7068 patients with coronary heart disease. By comparison, the odds ratios in the Reykjavik Study for coronary heart disease were somewhat weaker for the erythrocyte sedimentation rate (1.30; 95 percent confidence interval, 1.13 to 1.51) and the von Willebrand factor concentration (1.11; 95 percent confidence interval, 0.97 to 1.27) but generally stronger for established risk factors, such as an increased total cholesterol concentration (2.35; 95 percent confidence interval, 2.03 to 2.74) and cigarette smoking (1.87; 95 percent confidence interval, 1.62 to 2.16). CONCLUSIONS: C-reactive protein is a relatively moderate predictor of coronary heart disease. Recommendations regarding its use in predicting the likelihood of coronary heart disease may need to be reviewed.

Integrity signals

Registry

Crossref · 10.1056/nejmoa032804

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 4,694
Self-citation
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men
Köenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,952
Self-citation
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692
Self-citation
Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
Ridker, P. M., Rifai, N., Clearfield, M., Downs, J. R., Weis, S. E., Miles, J. S., & Gotto, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442601 · Cited by 1,557
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488

Flagged first, then by citations

Show all 37 references

Research works printed but not linked: 2

Tulinius H, 1997, Cancer Epidemiol Biomarkers Prev, 6, 863
Witherell H, 1999, Gastroenterology, 116, A355

Sorted by citations

Items 401–500 of 1,014

Time‐Efficient Inspiratory Muscle Strength Training Lowers Blood Pressure and Improves Endothelial Function, NO Bioavailability, and Oxidative Stress in Midlife/Older Adults With Above‐Normal Blood Pressure
Craighead, D. H., Heinbockel, T. C., Freeberg, K. A., Rossman, M. J., Jackman, R. A., Jankowski, L. R., Hamilton, M. N., Ziemba, B. P., Reisz, J. A., D’Alessandro, A., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.020980 · Cited by 128
Inflammation and thrombosis in diabetes
Hess, K., & Grant, P. J. (2011) · Thrombosis and Haemostasis · doi:10.1160/ths10-11-0739 · Cited by 117
Rosuvastatin in Diabetic Hemodialysis Patients
Holdaas, H., Holme, I., Schmieder, R. E., Jardine, A. G., Zannad, F. M., Norby, G. E., & Fellström, B. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010090987 · Cited by 118
N6-Methyladenosine RNA Modification in Inflammation: Roles, Mechanisms, and Applications
Luo, J., Xu, T., & Sun, K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.670711 · Cited by 117
Effect of Periodontal Treatment on Serum C‐Reactive Protein Levels: A Systematic Review and Meta‐Analysis
Ioannidou, E., Malekzadeh, T., & Dongari‐Bagtzoglou, A. (2006) · Journal of Periodontology · doi:10.1902/jop.2006.050443 · Cited by 118
Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study
Conen, D., Ridker, P. M., Buring, J. E., & Glynn, R. J. (2007) · BMJ · doi:10.1136/bmj.39269.672188.ae · Cited by 119
New Drugs for the Treatment of Diabetes Mellitus
McGuire, D. K., & Inzucchi, S. E. (2008) · Circulation · doi:10.1161/circulationaha.107.704080 · Cited by 118
CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool?
Coventry, B. J., Ashdown, M. L., Quinn, M. A., Markovic, S. N., Yatomi-Clarke, S., & Robinson, A. P. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-102 · Cited by 116
C‐reactive protein as a predictor of postoperative infective complications following elective colorectal resection
MacKay, G. J., Molloy, R. G., & O’Dwyer, P. J. (2010) · Colorectal Disease · doi:10.1111/j.1463-1318.2010.02236.x · Cited by 120
Acute phase protein and cytokine levels in serum and saliva: A comparison of detectable levels and correlations in a depressed and healthy adolescent sample
Byrne, M. L., O’Brien-Simpson, N. M., Reynolds, E. C., Walsh, K. A., Laughton, K., Waloszek, J. M., Woods, M. J., Trinder, J., & Allen, N. B. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.08.010 · Cited by 144
Epidemiology, risk factors and management of cardiovascular diseases in IBD
Singh, S., Kullo, I. J., Pardi, D. S., & Loftus, E. V. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.202 · Cited by 116
C-Reactive Protein, Inflammatory Conditions, and Cardiovascular Disease Risk
Dhingra, R., Gona, P. N., Nam, B., D’Agostino, R. B., Wilson, P. W. F., Benjamin, E. J., & O’Donnell, C. J. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.08.037 · Cited by 116
Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium
Ding, H., & Triggle, C. R. (2005) · Vascular Health and Risk Management · doi:10.2147/vhrm.1.1.55.58939 · Cited by 118
CRP and suPAR are differently related to anthropometry and subclinical organ damage
Lyngbæk, S., Sehestedt, T. B., Marott, J. L., Hansen, T. W., Olsen, M. H., Andersen, O., Linneberg, A. R., Madsbad, S., Haugaard, S. B., Eugen‐Olsen, J., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.03.040 · Cited by 116
Depression and Kidney Transplantation
Chilcot, J., Spencer, B. W. J., Maple, H., & Mamode, N. (2013) · Transplantation · doi:10.1097/01.tp.0000438212.72960.ae · Cited by 116
The effect of selenium supplementation on coronary heart disease: A systematic review and meta-analysis of randomized controlled trials
Ju, W., Li, X.-T., Li, Z., Wu, G., Fu, X., Yang, X., Zhang, X. Q., & Gao, X. (2017) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2017.04.009 · Cited by 117
Perceived weight discrimination and C‐reactive protein
Sutin, A. R., Stephan, Y., Luchetti, M., & Terracciano, A. (2014) · Obesity · doi:10.1002/oby.20789 · Cited by 126
Multimarker Prediction of Coronary Heart Disease Risk
Kim, H. C., Greenland, P., Rossouw, J. E., Manson, J. E., Cochrane, B. B., Lasser, N. L., Limacher, M. C., Lloyd‐Jones, D. M., Margolis, K. L., & Robinson, J. G. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.047 · Cited by 113
Ethnicity Modifies the Relationships of Insulin Resistance, Inflammation, and Adiponectin With Obesity in a Multiethnic Asian Population
Khoo, C. M., Sairazi, S., Taslim, S., Gardner, D. S.-L., Wu, Y., Lee, J. Y., van Dam, R. M., & Tai, E. S. (2011) · Diabetes Care · doi:10.2337/dc10-2097 · Cited by 113
Indices of low-grade inflammation in polycystic ovary syndrome
DIAMANTI‐KANDARAKIS, E., PATERAKIS, T., & KANDARAKIS, H. A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1365.015 · Cited by 112
Persistently raised C‐reactive protein levels are associated with advanced periodontal disease
Linden, G. J., McClean, K., Young, I. S., Evans, A., & Kee, F. (2008) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2008.01288.x · Cited by 112
Strengthening causal inference in cardiovascular epidemiology through Mendelian randomization
Smith, G. D., Timpson, N. J., & Ebrahim, S. B. J. (2008) · Annals of Medicine · doi:10.1080/07853890802010709 · Cited by 112
Risk Prediction of Coronary Heart Disease Based on Retinal Vascular Caliber (from the Atherosclerosis Risk In Communities [ARIC] Study)
McGeechan, K., Liew, G., Macaskill, P., Irwig, L., Klein, R., Sharrett, A. R., Klein, B. E. K., Wang, J. J., Chambless, L. E., & Wong, T. Y. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.094 · Cited by 112
On the transdiagnostic nature of peripheral biomarkers in major psychiatric disorders: A systematic review
Pinto, J. V., Moulin, T. C., & Amaral, O. B. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.10.001 · Cited by 103
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease – a perspective
KONES, R. J. (2010) · Drug Design Development and Therapy · doi:10.2147/dddt.s10812 · Cited by 112
Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100
Castelnuovo, A. F. D., Iacoviello, L., Vermylen, J., de Gaetano, G., Crescente, M., & Cerletti, C. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-08-0530 · Cited by 113
S100A12 and the S100/Calgranulins
Oesterle, A., & Bowman, M. A. H. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.302072 · Cited by 111
A link between inflammation and thrombosis in atherosclerotic cardiovascular diseases: Clinical and therapeutic implications
Oikonomou, E. K., Leopoulou, M., Theofilis, P., Antonopoulos, A. S., Siasos, G., Latsios, G., Mystakidi, V. C., Antoniades, C. A., & Tousoulis, D. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.07.027 · Cited by 117
C-reactive protein as a predictor of disease in smokers and former smokers: a review
Tonstad, S., & Cowan, J. L. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02179.x · Cited by 111
The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes
Wannamethee, S. G., LENNON, L. T., & Shaper, A. G. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.01.019 · Cited by 111
Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia
Kovacs, A., Tornvall, P., Nilsson, R., Tegner, J. N., Hamsten, A., & Björkegren, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706027104 · Cited by 111
Cholesterol Feeding Increases C-Reactive Protein and Serum Amyloid A Levels in Lean Insulin-Sensitive Subjects
Tannock, L. R., O’Brien, K. D., Knopp, R. H., Retzlaff, B. M., Fish, B. E., Wener, M. H., Kahn, S. E., & Chait, A. (2005) · Circulation · doi:10.1161/circulationaha.104.506188 · Cited by 113
Exercise decreases oxidative stress and inflammation and restores renal dopamine D1 receptor function in old rats
Asghar, M., George, L., & Lokhandwala, M. F. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00272.2007 · Cited by 111
Hemostatic Factors and Risk of Coronary Heart Disease in General Populations: New Prospective Study and Updated Meta-Analyses
Willeit, P., Thompson, A., Aspelund, T., Rumley, A., Eiríksdóttir, G., Lowe, G. D. O., Gudnason, V. G., & Angelantonio, E. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055175 · Cited by 112
Self-citation
Biological foundation for periodontitis as a potential risk factor for atherosclerosis
Chun, Y. P., Chun, K. J., Olguin, D., & Wang, H. (2004) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2004.00771.x · Cited by 110
Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk
Saevarsdóttir, S., Óskarsson, Ó. Ö., Aspelund, T., Eiríksdóttir, G., Vı́kingsdóttir, T., Gudnason, V. G., & Valdimarsson, H. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041431 · Cited by 109
Self-citation
No Effect of C-Reactive Protein on Early Atherosclerosis Development in Apolipoprotein E*3-Leiden/Human C-Reactive Protein Transgenic Mice
Trion, A., de Maat, M. P. M., Jukema, J. W., van der Laarse, A., Maas, M., Offerman, E. H., Havekes, L. M., Szalai, A. J., Princen, H. M. G., & EMEIS, J. J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000171992.36710.1e · Cited by 109
Association of C-Reactive Protein With Cardiovascular Disease Mortality According to Diabetes Status
Kengne, A. P., Batty, G. D., Hamer, M., Stamatakis, E., & Czernichow, S. (2012) · Diabetes Care · doi:10.2337/dc11-1588 · Cited by 105
A Negative Carotid Plaque Area Test Is Superior to Other Noninvasive Atherosclerosis Studies for Reducing the Likelihood of Having Underlying Significant Coronary Artery Disease
Brook, R. D., Bard, R. L., Patel, S. V., Rubenfire, M., Clarke, N. S., Kazerooni, E. A., Wakefield, T. W., Henke, P. K., & Eagle, K. A. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000200079.18690.60 · Cited by 108
Inflammation and Infection Do Not Promote Arterial Aging and Cardiovascular Disease Risk Factors among Lean Horticulturalists
Gurven, M., Kaplan, H., Winking, J., Eid Rodriguez, D., Vasunilashorn, S., Kim, J. K., Finch, C., & Crimmins, E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006590 · Cited by 107
Obesity and the cardiovascular health effects of fine particulate air pollution
Weichenthal, S., Hoppin, J. A., & Reeves, F. (2014) · Obesity · doi:10.1002/oby.20748 · Cited by 110
Immunological effects of behavioral activation with exercise in major depression: an exploratory randomized controlled trial
Euteneuer, F., Dannehl, K., del Rey, A., Engler, H., Schedlowski, M., & Rief, W. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.76 · Cited by 107
Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease
Osman, R., L’Allier, P. L., Elgharib, N. Z., & Tardif, J. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.221 · Cited by 111
Association of HIV Infection and HIV/HCV Coinfection With C-Reactive Protein Levels
Reingold, J. S., WANKE, C. A., Kotler, D. P., Lewis, C. E., Tracy, R. P., Heymsfield, S. B., Tien, P. C., Bacchetti, P., Scherzer, R., Grünfeld, C., et al. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181685727 · Cited by 107
Tracking of High-Sensitivity C-Reactive Protein after an Initially Elevated Concentration: The JUPITER Study
Glynn, R. J., MacFadyen, J. G., & Ridker, P. M. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.120642 · Cited by 107
Elevated Serum Chemerin Levels are Associated with the Presence of Coronary Artery Disease in Patients with Metabolic Syndrome
Dong, B., Ji, W., & Zhang, Y. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.5025 · Cited by 106
Pro-Inflammatory Markers in Relation to Cardiovascular Disease in HIV Infection. A Systematic Review
Vos, A. G., Idris, N. S., Barth, R. E., Klipstein‐Grobusch, K., & Grobbee, D. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147484 · Cited by 106
A dose‐response study of hormone replacement in young hypogonadal women: effects on intima media thickness and metabolism
Ostberg, J. E., Storry, C., Donald, A. E., Hosseinzadeh‐Attar, M. J., Halcox, J., & Conway, G. S. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02772.x · Cited by 106
Inflammatory Bowel Disease Is Not a Risk Factor for Cardiovascular Disease Mortality: Results from a Systematic Review and Meta-Analysis
Dorn, S. D., & Sandler, R. S. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.01018.x · Cited by 106
C-reactive protein at the interface between innate immunity and inflammation
Peisajovich, A., Marnell, L. L., Mold, C., & Clos, T. W. D. (2008) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.4.3.379 · Cited by 110
Genetic Influence on Inflammation Variables in the Elderly
de Maat, M. P. M., Bladbjerg, E., Hjelmborg, J., Bathum, L., Jespersen, J., & Christensen, K. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000143856.01669.e7 · Cited by 104
An overview of lipid abnormalities in patients with inflammatory bowel disease.
Agouridis, A. P., Elisaf, M., & Milionis, H. J. (2011) · Europe PMC (PubMed Central) · Cited by 103
Biological and behavioural explanations of social inequalities in coronary heart disease: the Whitehall II study
Marmot, M. G., Shipley, M. J., Hemingway, H., Head, J. A., & Brunner, E. J. (2008) · Diabetologia · doi:10.1007/s00125-008-1144-3 · Cited by 110
Effects of older age on fibrin D‐dimer, C‐reactive protein, and other hemostatic and inflammatory variables in men aged 60–79 years
Rumley, A., Emberson, J., Wannamethee, S. G., LENNON, L. T., Whincup, P. H., & Lowe, G. D. O. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01889.x · Cited by 105
Self-citation
Metabolic Consequences of Sleep-Disordered Breathing
Jun, J. C., & Polotsky, V. Y. (2009) · ILAR Journal · doi:10.1093/ilar.50.3.289 · Cited by 107
Multiple Inflammatory Biomarkers in Relation to Cardiovascular Events and Mortality in the Community
Schnabel, R. B., Yin, X., Larson, M. G., Yamamoto, J. F., Fontes, J. D., Kathiresan, S., Rong, J., Levy, D. A., Keaney, J. F., Wang, T. J., et al. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.301174 · Cited by 104
The obesity epidemic and its cardiovascular consequences
Behn, A., & Ur, E. (2006) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000231406.84554.96 · Cited by 104
Evidence that high von Willebrand factor and low ADAMTS‐13 levels independently increase the risk of a non‐fatal heart attack
Crawley, J. T. B., Lane, D. A., Woodward, M., Rumley, A., & Lowe, G. D. O. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02902.x · Cited by 104
Self-citation
Comparison of Usefulness of Inflammatory Markers in Patients With Versus Without Peripheral Arterial Disease in Predicting Adverse Cardiovascular Outcomes (Myocardial Infarction, Stroke, and Death)
Beckman, J. A., Preis, O., Ridker, P. M., & Gerhard‐Herman, M. D. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.07.041 · Cited by 104
Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure
Windram, J. D., LOH, P., Rigby, A. S., Hanning, I., Clark, A. L., & Cleland, J. G. F. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.03.044 · Cited by 104
The Association of C-Reactive Protein and CRP Genotype with Coronary Heart Disease: Findings from Five Studies with 4,610 Cases amongst 18,637 Participants
Lawlor, D. A., Harbord, R. M., Timpson, N. J., Lowe, G. D. O., Rumley, A., Gaunt, T. R., Baker, I. A., YARNELL, J. W. G., Mika Kivimaki, B., Meena Kumari, B., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003011 · Cited by 105
Self-citation
How Predictive Is Breast Arterial Calcification of Cardiovascular Disease and Risk Factors When Found at Screening Mammography?
Kataoka, M., Warren, R. M. L., Luben, R., Camus, J., Denton, E., Sala, E., Day, N. M., & Khaw, K. (2006) · American Journal of Roentgenology · doi:10.2214/ajr.05.0365 · Cited by 103
Reviewing the Benefits of Physical Activity During Cancer Survivorship
Sabiston, C. M., & Brunet, J. (2011) · American Journal of Lifestyle Medicine · doi:10.1177/1559827611407023 · Cited by 116
Serum C-reactive protein as a marker for wellness assessment.
Kao, P. C., Shiesh, S. C., & Wu, T. J. (2006) · PubMed · Cited by 101
Systemic Inflammation in Older Adults With Asthma-COPD Overlap Syndrome
Fu, J., McDonald, V. M., Gibson, P. G., & Simpson, J. L. (2014) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2014.6.4.316 · Cited by 102
A Prospective Study of Inflammation Markers and Endometrial Cancer Risk in Postmenopausal Hormone Nonusers
Wang, T., Rohan, T. E., Gunter, M. J., Xue, X., Wactawski‐Wende, J., Rajpathak, S. N., Cushman, M., Strickler, H. D., Kaplan, R. C., Wassertheil-Smoller, S. W., et al. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-1222 · Cited by 102
PET Imaging of Atherosclerotic Disease: Advancing Plaque Assessment from Anatomy to Pathophysiology
Evans, N. R., Tarkin, J. M., Chowdhury, M. M., Warburton, E. A., & Rudd, J. H. F. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-016-0584-3 · Cited by 109
Inflammation in End-Stage Renal Disease – A Fire that Burns within
Stenvinkel, P. (2005) · KARGER eBooks · doi:10.1159/000085525 · Cited by 102
Lipids, atherosclerosis and CVD risk: Is CRP an innocent bystander?
Nordestgaard, B. G., & Zacho, J. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.07.005 · Cited by 101
C-reactive protein: Risk factor, biomarker and/or therapeutic target?
Genest, J. J. (2010) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(10)71061-8 · Cited by 102
C-Reactive Protein and Risk of First-Ever Ischemic and Hemorrhagic Stroke in a General Japanese Population
Wakugawa, Y., Kiyohara, Y., Tanizaki, Y., Kubo, M., Ninomiya, T., Hata, J., Doi, Y., Okubo, K., Oishi, Y., Shikata, K., et al. (2005) · Stroke · doi:10.1161/01.str.0000194958.88216.87 · Cited by 102
Role of Nonenhanced Multidetector CT Coronary Artery Calcium Testing in Asymptomatic and Symptomatic Individuals
Nasir, K., & Clouse, M. E. (2012) · Radiology · doi:10.1148/radiol.12110810 · Cited by 102
Obesity and cardiovascular outcomes: a review
Ghoorah, K., Campbell, P. T., Kent, A., Maznyczka, A., & Kunadian, V. (2014) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872614523349 · Cited by 101
Are Markers of Inflammation More Strongly Associated with Risk for Fatal Than for Nonfatal Vascular Events?
Sattar, N. A., Murray, H. M., Welsh, P. I., Blauw, G. J., Buckley, B. M., Cobbe, S. M., de Craen, A. J. M., Lowe, G. D. O., Jukema, J. W., Macfarlane, P. W., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000099 · Cited by 105
Self-citation
Biomarkers of Infection and Sepsis
Opal, S. M., & Wittebole, X. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2019.08.002 · Cited by 101
Interleukin 6 −174 G/C Promoter Polymorphism and Risk of Coronary Heart Disease
Sie, M. P. S., Sayed‐Tabatabaei, F. A., Oei, H.-H. S., Uitterlinden, A. G., Pols, H. A. P., Albert Hofman, D., van Duijn, C. M., & Witteman, J. C. M. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000194099.65024.17 · Cited by 102
The Clinical Utility of High-Sensitivity C-Reactive Protein in Cardiovascular Disease and the Potential Implication of JUPITER on Current Practice Guidelines
Mora, S., Musunuru, K., & Blumenthal, R. S. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.109728 · Cited by 100
Impact of improved cookstoves on indoor air pollution and adverse health effects among Honduran women
Clark, M., Peel, J., Burch, J., Nelson, T., Robinson, M. M., Conway, S., Bachand, A., & Reynolds, S. (2009) · International Journal of Environmental Health Research · doi:10.1080/09603120902842705 · Cited by 104
Role of Matrix Metalloproteinase-8 in Atherosclerosis
Lenglet, S., Mach, F., & Montecucco, F. (2013) · Mediators of Inflammation · doi:10.1155/2013/659282 · Cited by 101
High-density lipoprotein: Antioxidant and anti-inflammatory properties
Navab, M., Yu, R. C., Gharavi, N. M., Huang, W. M., Ezra, N., Lotfizadeh, A., Anantharamaiah, G. M., Alipour, N., Lenten, B. J. V., Reddy, S. T., et al. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0026-3 · Cited by 101
Ah receptor represses acute-phase response gene expression without binding to its cognate response element
Patel, R. D., Murray, I. A., Flaveny, C. A., Kusnadi, A. R., & Perdew, G. H. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.24 · Cited by 101
Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance—the Chennai Urban Rural Epidemiology Study (CURES)
Deepa, R., Velmurugan, K., Arvind, K., Pillarisetti, S., Sientay, C., Saxena, U., & Mohan, V. (2006) · Metabolism · doi:10.1016/j.metabol.2006.05.008 · Cited by 101
CRP or not CRP? That Is the Question
Pepys, M. B. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000169644.88847.28 · Cited by 101
Self-citation
Social isolation in childhood and adult inflammation: evidence from the National Child Development Study
Lacey, R. E., Kumari, M., & Bartley, M. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.08.007 · Cited by 99
Anti–lipoprotein lipase antibodies: A new player in the complex atherosclerotic process in systemic lupus erythematosus?
de Carvalho, J. F., Borba, E. F., Viana, V. D. S. T., Bueno, C., Leon, E. P., & Bonfá, E. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20630 · Cited by 100
FcγRIIB Mediates C-Reactive Protein Inhibition of Endothelial NO Synthase
Mineo, C., Gormley, A. K., Yuhanna, I. S., Osborne-Lawrence, S. L., Gibson, L. L., Hahner, L., Shohet, R. V., Black, S., Salmon, J. E., Samols, D. R., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000194323.77203.fe · Cited by 100
Hyperglycemia repression of miR-24 coordinately upregulates endothelial cell expression and secretion of von Willebrand factor
Xiang, Y., Cheng, J., Wang, D., Hu, X., Xie, Y., Stitham, J., Atteya, G. A., Du, J., Tang, W. H., Lee, S. H., et al. (2015) · Blood · doi:10.1182/blood-2015-01-620278 · Cited by 99
Atherogenesis: the role of inflammation and infection
Mahmoudi, M., Curzen, N. P., & Gallagher, P. J. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02503.x · Cited by 99
Associations of inflammatory markers with coronary artery calcification: Results from the Multi-Ethnic Study of Atherosclerosis
Jenny, N. S., Brown, E. R., Detrano, R., Folsom, A. R., Saad, M. F., Shea, S., Szklo, M., Herrington, D. M., & Jacobs, D. R. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.08.037 · Cited by 99
CRP after 2004
Agrawal, A. C. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.09.028 · Cited by 98
Endothelial cell markers from clinician's perspective
Rakočević, J., Orlic, D. N., Ajtić, O. M., Tomasevic, M. V., Dobric, M. R., Zlatic, N., Milašinović, D., Stankovic, G. R., Ostojić, M., & Labudović‐Borović, M. (2017) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2017.02.005 · Cited by 98
Hazelnut-enriched diet improves cardiovascular risk biomarkers beyond a lipid-lowering effect in hypercholesterolemic subjects
Örem, A., Yücesan, F. B., Örem, C., Akçan, B., Kural, B. V., Alasalvar, C., & Shahidi, F. (2012) · Journal of clinical lipidology · doi:10.1016/j.jacl.2012.10.005 · Cited by 100
C-reactive protein, an ‘intermediate phenotype’ for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/β-adrenergic pathway loci
Wessel, J., Moratorio, G., Rao, F., Mahata, M., Zhang, L., Greene, W., Rana, B. K., Kennedy, B. P., Khandrika, S., Huang, P., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e328011753e · Cited by 97
C-Reactive Protein (CRP) Gene Polymorphisms, CRP Levels, and Risk of Incident Coronary Heart Disease in Two Nested Case-Control Studies
Pai, J. K., Mukamal, K. J., Rexrode, K. M., & Rimm, E. B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001395 · Cited by 97
Guía europea de prevención cardiovascular en la práctica clínica: Adaptación española del CEIPC 2008
Lobos, J. M., Royo‐Bordonada, M. Á., Brotons, C., Álvarez-Sala, L., Armario, P., Maiques, A., Mauricio, D., Sans, S., Villar, F., Lizcano‐Álvarez, A., et al. (2008) · Revista Española de Salud Pública · doi:10.1590/s1135-57272008000600002 · Cited by 97
Circulating Interleukin-10 and Risk of Cardiovascular Events
Welsh, P. I., Murray, H. M., Ford, I., Trompet, S., de Craen, A. J. M., Jukema, J. W., Stott, D. J., McInnes, I. B., Packard, C. J., Westendorp, R. G. J., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.231795 · Cited by 102
C-reactive protein and lung diseases
Agassandian, M., Shurin, G. V., Ma, Y., & Shurin, M. R. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.05.016 · Cited by 96
The Effects of Effort-Reward Imbalance on Inflammatory and Cardiovascular Responses to Mental Stress
Hamer, M., Williams, E. D., Vuonovirta, R., Giacobazzi, P., Gibson, E. L., & Steptoe, A. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000221227.02975.a0 · Cited by 95
C-reactive protein and atherogenesis: From fatty streak to clinical event
Bisoendial, R. J., Kastelein, J. J. P., & Stroes, E. S. G. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.04.053 · Cited by 95
High Bone Turnover Is an Independent Predictor of Mortality in the Frail Elderly
Sambrook, P. N., Chen, C. J., MARCH, L. M., Cameron, I. D., Cumming, R. G., Lord, S. R., Simpson, J. M., & Seibel, M. J. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060104 · Cited by 96

Authors: Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V.
Affiliations: University of Cambridge (GB)
The Royal Free Hospital (GB)
Roche (Japan) (JP)
Glasgow Royal Infirmary (GB)
Icelandic Heart Association (IS)
ORCID: Danesh, John
Hirschfield, Gideon M.
Lowe, Gordon D.O.
Pepys, Mark B.
Gudnason, Vilmundur
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2004-04
Volume: 350
Issue: 14
Pages: 1387-1397
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa032804
OpenAlex: W2058709767
Cited by: 2,953
References: 37
Citations by year: 2026: 39 · 2025: 38 · 2024: 66 · 2023: 43 · 2022: 65 · 2021: 79 · 2020: 102 · 2019: 79 · 2018: 97 · 2017: 99 · 2016: 113 · 2015: 121 · 2014: 144 · 2013: 122 · 2012: 170
FWCI: 238.23
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords: C-reactive protein, coronary artery disease, inflammation, circulating inflammatory markers, erythrocyte sedimentation rate, von Willebrand factor, myocardial infarction, cardiovascular risk prediction, within-person variability, total cholesterol, cigarette smoking, Reykjavik Study
MeSH terms: Aged, Blood Sedimentation, C-Reactive Protein, Coronary Disease, Female, Humans, Inflammation, Male, Middle Aged, Prospective Studies, Risk, Risk Factors, von Willebrand Factor, Meta-Analysis as Topic, Biomarkers, Odds Ratio, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks